HCR5001 Public Health Assessment Brief 2026 | Arden University

HCR5001 Assessment Brief

Assessment Type : Report Intervention

Introduction

Sexually transmitted infections (STIs) remain a major public health challenge in the United Kingdom, with rising rates of gonorrhoea, syphilis, and chlamydia placing increasing pressure on sexual health services. In response, the UK Health Security Agency (UKHSA) developed the Sexually Transmitted Infections Prioritisation Framework (STI‑PF) (2024–2026), a structured, evidence‑based tool designed to support local authorities and sexual health commissioners in prioritising interventions that reduce adverse health outcomes and inequalities. This essay critically examines the modern public health principles underpinning the STI‑PF, identifies and evaluates its key elements, reviews the evidence supporting the intervention, and discusses its strengths and limitations.

1. Concepts and Principles of Modern Public Health Underpinning the STI‑PF

Modern public health is grounded in a set of core principles that emphasise population‑level action, equity, prevention, evidence‑based decision‑making, and system‑wide coordination. The STI‑PF reflects these principles throughout its design and implementation.

Population Health Approach

A population health approach focuses on improving health outcomes across entire communities rather than solely treating individuals. The STI‑PF begins with a structured situation assessment, requiring local areas to analyse epidemiological data, service demand, and local patterns of infection. This aligns with the principle that effective public health interventions must be informed by robust surveillance and an understanding of population‑level trends. By emphasising local variation in STI burden, the framework supports tailored interventions that reflect the needs of specific communities.

Health Equity and Inclusion Health

Modern public health prioritises reducing health inequalities. STIs disproportionately affect certain groups, including young people, men who have sex with men (MSM), ethnic minority communities, and individuals experiencing socioeconomic disadvantage. The STI‑PF explicitly identifies inequity as a core concern, stating that STIs “impact different groups unequally” and that interventions should prioritise groups at greatest risk of adverse outcomes. This reflects inclusion‑health principles, which aim to address structural barriers to care and ensure equitable access to prevention, testing, and treatment.

Evidence‑Based Public Health

Evidence‑based practice is central to modern public health. The STI‑PF is described as an “evidence‑based and structured” tool, incorporating epidemiological evidence, behavioural data, service‑level information, and expert consensus. The framework includes a Modified Delphi process, a recognised method for achieving expert agreement on complex public health priorities. This ensures that decisions are grounded in high‑quality evidence rather than political or organisational pressures.

Systems Thinking and Multi‑Level Action

Systems thinking recognises that health outcomes are shaped by interactions between individuals, services, and broader social and environmental factors. The STI‑PF adopts a systems perspective by analysing multiple drivers of STI trends, including population behaviour, testing technology, service capacity, and pathogen evolution. This multi‑level approach ensures that interventions address root causes rather than isolated symptoms.

Prevention and Early Intervention

Prevention is a cornerstone of modern public health. The STI‑PF emphasises preventing adverse health outcomes through primary prevention (education, condom promotion), secondary prevention (screening and early diagnosis), and tertiary prevention (reducing complications). This aligns with the shift in public health towards proactive, upstream interventions that reduce long‑term harm and cost.

Accountability, Monitoring, and Continuous Improvement

Modern public health requires transparent evaluation and accountability. The STI‑PF includes a comprehensive Monitoring and Evaluation Plan (MEP) with impact indicators, process indicators, and logic models. This ensures that interventions are measurable, adaptable, and responsive to emerging trends.

2. Key Elements of the STI‑PF and How They Would Be Evaluated

The STI‑PF consists of three core elements—Situation, Target Groups, and Interventions—supported by a structured evaluation framework.

Situation Assessment

The first element requires local areas to assess the “situation,” including:

• Epidemiological burden
• Local patterns of infection
• Service demand and supply
• Testing trends
• Resource constraints
• This ensures interventions are grounded in real local needs rather than generic national priorities.

Target Group Identification

The second element involves identifying groups at highest risk of adverse outcomes or with the greatest barriers to access. This includes:

• Young people
• MSM
• Ethnic minority groups
• Individuals experiencing socioeconomic disadvantage
• Targeting these groups operationalises the framework’s equity principles.

Intervention Selection and Tailoring

The third element requires selecting interventions that are:

• Evidence‑based
• Feasible within local resources
• Tailored to local needs
• Examples include expanded testing, digital outreach, partner notification, and education programmes.
• Evaluation of the Intervention
• Evaluation is guided by the Monitoring and Evaluation Plan.

Impact Indicators

Measure whether the intervention achieves intended outcomes:

• Reduction in STI incidence
• Reduction in adverse health outcomes
• Reduction in inequalities
• Process Indicators
• Measure whether the intervention is implemented correctly:
• Number of tests delivered
• Uptake among target groups
• Timeliness of treatment
• Partner notification success rates

Logic Model Evaluation

The STI‑PF identifies four prerequisites for impact:

• Prevent new infections
• Improve access
• Improve service quality
• Reduce barriers
• Evaluation checks whether these prerequisites are being met.

3. Evidence Supporting the STI‑PF

The STI‑PF is supported by multiple forms of evidence.

Epidemiological Evidence

Recent UK data show rising rates of gonorrhoea and syphilis, with persistent inequalities in STI burden. This epidemiological evidence justifies prioritisation and targeted interventions.

• Evidence on Drivers of STI Trends
• The framework reviews evidence on:
• Behavioural changes
• Testing technology
• Service‑level constraints
• Pathogen evolution
• This supports the need for a systems‑based intervention.
• Consensus Evidence

The Modified Delphi process strengthens the validity of recommended interventions by incorporating expert consensus.

Cost and Outcome Evidence

The framework includes methods for estimating secondary care costs associated with STIs, supporting prioritisation of interventions that reduce long‑term harm and cost.

Monitoring and Evaluation Evidence

The MEP provides evidence‑based indicators and logic models to track progress, ensuring the intervention is measurable and adaptable.

4. Critical Discussion of Strengths and Limitations

• A critical appraisal highlights both strengths and limitations of the STI‑PF.
• Strengths
• Evidence‑Based Structure
• Grounded in epidemiology, consensus methods, and cost analysis.
• Equity‑Focused
• Prioritises underserved groups and reduces inequalities.
• Flexible and Locally Adaptable
• Allows local tailoring based on needs.
• Clear Monitoring Framework
• Impact and process indicators support accountability.
• Limitations
• Resource Constraints
• Local authorities may lack funding to implement recommended interventions.
• Data Quality and Availability
• Some areas may have incomplete surveillance data.
• Variability in Local Implementation
• Different regions may interpret prioritisation differently.
• Fragmentation of Sexual Health Planning
• HIV outcomes are addressed separately, which may fragment service planning.

Conclusion

The UK’s Sexually Transmitted Infections Prioritisation Framework represents a modern, evidence‑based public health intervention designed to reduce STI‑related harm and inequalities. Grounded in core public health principles—population health, equity, prevention, systems thinking, and accountability—it provides a structured approach to prioritising interventions based on local needs. While the framework has significant strengths, including its evidence‑based design and focus on equity, it also faces challenges related to resource constraints, data quality, and variability in implementation. Nevertheless, the STI‑PF offers a robust foundation for improving sexual health outcomes across the UK.

UK Government & Agency Publications

• UK Health Security Agency (UKHSA). Sexually Transmitted Infections Prioritisation Framework (STI‑PF) 2024–2026. London: UKHSA.
• UK Health Security Agency (UKHSA). Sexually Transmitted Infections and Screening for Chlamydia in England: 2023 Annual Report. London: UKHSA.
• Department of Health and Social Care (DHSC). Towards Zero: The Government’s Strategy for Sexual Health and HIV. London: DHSC.
• National Institute for Health and Care Excellence (NICE). Sexually Transmitted Infections: Prevention and Control. NICE Guideline NG221.
• Public Health England (PHE). Health Equity Assessment Tool (HEAT). London: PHE.
• Office for Health Improvement and Disparities (OHID). Sexual and Reproductive Health Profiles: Local Authority Data. London: OHID.

Peer‑Reviewed Academic Literature

• Sonnenberg, P., Clifton, S., Beddows, S., et al. “Epidemiology of STIs in the UK: Trends and Determinants.” The Lancet Public Health.
• Mercer, C.H., et al. “Changes in Sexual Behaviour and STI Risk in Britain: Evidence from Natsal‑3.” The BMJ.
• Hughes, G., & Field, N. “The Epidemiology of Sexually Transmitted Infections in the UK.” Medicine.
• Wayal, S., et al. “Inequalities in Sexual Health: Evidence from National Surveys.” Sexually Transmitted Infections Journal.
• Wilkinson, R., & Marmot, M. Social Determinants of Health: The Solid Facts. WHO Europe.
• Trotter, C., et al. “Partner Notification and STI Control: A Systematic Review.” Sexually Transmitted Diseases.
• Cassell, J., et al. “The Role of Public Health Systems in STI Prevention.” Journal of Public Health.

Evidence on Public Health Principles & Systems Thinking

• Marmot, M. The Health Gap: The Challenge of an Unequal World. Bloomsbury.
• Kickbusch, I. “The Development of the Modern Public Health System.” Health Promotion International.
• Green, J., & Thorogood, N. Qualitative Methods for Health Research. Sage.
• Rutter, H., et al. “The Need for a Complex Systems Model in Public Health.” The Lancet.
• Brownson, R.C., et al. Evidence‑Based Public Health. Oxford University Press.
• Behavioural & Social Evidence Relevant to STI Trends
• Natsal (National Survey of Sexual Attitudes and Lifestyles). Natsal‑3 Key Findings.
• Mitchell, H., et al. “Behavioural Drivers of STI Transmission in Young People.” Journal of Adolescent Health.
• McDonagh, L., et al. “Digital Sexual Health Interventions: A Review.” Public Health.

Economic & Cost‑Effectiveness Evidence

• Turner, K.M.E., et al. “Cost‑Effectiveness of STI Screening Interventions.” Sexually Transmitted Infections Journal.
• Briggs, A., & Sculpher, M. Decision Modelling for Health Economic Evaluation. Oxford University Press.
• UKHSA. Secondary Care Costs Associated with STIs: Technical Annex.
• Monitoring & Evaluation Frameworks
• UKHSA. Monitoring and Evaluation Plan for STI‑PF.
• HM Treasury. The Magenta Book: Guidance for Evaluation.
• WHO. Monitoring and Evaluation of Sexual Health Programmes.
• Public Health England. Logic Model Toolkit for Public Health Interventions.
• Equity, Inclusion Health & Vulnerable Populations
• Luchenski, S., et al. “What Works in Inclusion Health: Evidence for Vulnerable Groups.” The Lancet.
• Public Health England. Inclusion Health: Applying All Our Health.
• Marmot Review Team. Fair Society, Healthy Lives. London: UCL Institute of Health Equity.
• STI‑Specific Clinical & Epidemiological Evidence
• Fifer, H., et al. “Gonorrhoea Resistance Trends in the UK.” The Lancet Infectious Diseases.
• Kingston, M., et al. “Syphilis in the UK: Clinical and Epidemiological Trends.” Sexually Transmitted Infections Journal.
• Horner, P., et al. “Chlamydia Screening: Evidence and Controversies.” The BMJ.
• WHO. Global STI Surveillance Report. Geneva: WHO.

Answer

Request Answer of this Assignment